EP 1011440 A1 20000628 - VACCINE AGAINST LIPOPOLYSACCHARIDE CORE
Title (en)
VACCINE AGAINST LIPOPOLYSACCHARIDE CORE
Title (de)
IMPFSTOFF GEGEN DEN KERN VON LIPOPOLYSACCHARIDEN
Title (fr)
VACCIN DIRIGE CONTRE LES NOYAUX DE LIPOPOLYSACCHARIDES
Publication
Application
Priority
- US 9809988 W 19980515
- US 4668097 P 19970516
Abstract (en)
[origin: WO9851217A1] Complete core LPS (lacking O-polysaccharide side chains) from Gram-negative bacteria are incorporated into a vaccine typically in liposomes. The complete core of E. coli K 12 is particularly useful. Upon administration to a mammal the vaccine stimulates synthesis of antibodies which are cross-protective against smooth and rough forms of LPS from at least two different Gram-negative bacterial strains having different core structures.
IPC 1-7
A61B 5/055; A61K 39/02; A61K 39/40; A61K 39/108; A61K 39/112; A61K 51/00; C07K 16/00
IPC 8 full level
A61K 9/127 (2006.01); A61K 39/02 (2006.01); A61K 39/102 (2006.01); A61K 39/108 (2006.01); A61K 39/112 (2006.01); A61K 39/295 (2006.01); A61K 39/39 (2006.01); A61K 47/02 (2006.01); A61P 39/02 (2006.01)
CPC (source: EP)
A61K 39/0275 (2013.01); A61P 39/02 (2017.12); A61K 2039/55555 (2013.01); Y02A 50/30 (2017.12)
Designated contracting state (EPC)
BE CH DE DK ES FR GB GR IE IT LI NL PT SE
DOCDB simple family (publication)
WO 9851217 A1 19981119; AU 7491298 A 19981208; CA 2289760 A1 19981119; EP 1011440 A1 20000628; EP 1011440 A4 20030806; JP 2001527562 A 20011225
DOCDB simple family (application)
US 9809988 W 19980515; AU 7491298 A 19980515; CA 2289760 A 19980515; EP 98922339 A 19980515; JP 54958998 A 19980515